Product name : GSK 1838705A
Item : cc268
Price : 200mg, $950;500mg, $1595; 1g $2390; 2g, $3590
contact : Send inquiry to: info@acesobio.com,or by fax to: 1-845-673-1239.
CAS : 1116235-97-2
Molecular Weight : 532.57
Formula : C₂₇H₂₉FN₈O₃
Storage : at -20°C
Additional information : We offer significant discount for bulky quantity order
|
Details: | |||||||||||||||||||||||||
GSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50 of 2.0 and 1.6 nM, respectively. GSK 1838705A blocks the in vitro proliferation of cell lines derived from solid and hematologic malignancies, including multiple myeloma and Ewing's sarcoma, and retards the growth of human tumor xenografts in vivo. Despite the inhibitory effect of GSK-1838705A on insulin receptor, minimal effects on glucose homeostasis were observed at efficacious doses. GSK1838705A also inhibits the anaplastic lymphoma kinase (ALK), which drives the aberrant growth of anaplastic large-cell lymphomas, some neuroblastomas, and a subset of non-small cell lung cancers. GSK1838705A inhibits ALK, with an IC50 of 0.5 nM, and causes complete regression of ALK-dependent tumors in vivo at well-tolerated doses. GSK1838705A is therefore a promising antitumor agent for therapeutic use in human cancers. [1][2]
Reference:
[1] Mol. Cancer Ther. 2009, 8, 2811-2820.
[2] Eur. J Cancer 2010, 46, 2357-2368.
Chemical Information
PLEASE KEEP THE PRODUCT UNDER -20℃ FOR LONG-TERM STORAGE. NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.
|
Related Products : |
|
|
|
|
||||||||
|
|
|
|